Mechanistically, this pathway functions as a compensatory response to impaired mitochondrial β-oxidation resulting from CypD deletion or depletion, and involves transcriptional upregulation of glucose regulatory molecules, improved glucose tolerance, expansion of insulin-producing β-cells and mild hyperinsulinemia, in vivo. This evidence concerns the gene INS and hyperinsulinism.